Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat

Laboratory Investigation

Volumn 74, Issue 1, 1996, Pages 265-278

  Tuchweber, Beatriz ^a,b,d,e   Desmoulière, Alexis ^a,c   Bochaton Piallat, Marie Luce ^a   Rubbia Brandt, Laura ^a   Gabbiani, Giulio ^a,e  

^a Centre Médical Universitaire   (Switzerland)

^b UNIVERSITY OF MONTREAL   (Canada)

^c CNRS   (France)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DESMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHOLESTASIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FIBROBLAST; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOPEROXIDASE STAINING; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTINS; ANIMALS; CELL DIVISION; CHOLESTASIS; COLLAGEN; DESMIN; FIBROBLASTS; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOENZYME TECHNIQUES; MALE; MICROSCOPY, CONFOCAL; PORTAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030032905     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Abdel-Aziz G, Rescan PY, Clément B, Lebeau G, Rissel M, Grimaud JA, Campion JP, and Guillouzo A (1991). Cellular sources of matrix proteins in experimentally induced cholestatic rat liver. J Pathol 164:167-174.
2. Aronson DC, De Haan J, James J, Bosch KS, Ketel AG, Houtkooper JM, and Heijmans HS (1988). Quantitative aspects of the parenchyma-stroma relationship in experimentally induced cholestasis. Liver 8:116-126.
3. Ballardini G, Groff P, Badiali de Giorgi L, Schuppan D, and Blanchi FB (1994). Ito cell heterogeneity: Desmin-negative Ito cells in normal rat liver. Hepatology 19:440-446.
4. Bhunchet E and Wake K (1992). Role of mesenchymal cell populations in porcine-serum induced rat liver fibrosis. Hepatology 6:1452-1473.
5. Border W and Noble NA (1994). Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286-1292.
6. Burt AD (1993). Cellular and molecular aspects of hepatic fibrosis. J Pathol 170:105-114.
7. Burt AD and MacSween RNM (1993). Bile-duct proliferation: Its true significance? Histopathology 23:599-602.
8. Chojkier M, Lyche KD, and Filip M (1988). Increased production of collagen in vivo by hepatocytes and non parenchymal cells in rats with carbon tetrachloride-induced hepatic fibrosis. Hepatology 8:808-814.
9. Clément B, Loréal O, Rescan PY, Levavasseur F, Diakonova M, Rissel M, L'Helgoualch H, and Guillouzo A (1992). Cellular origin of the hepatic extracellular matrix. In: Gressner AM and Ramadori G, editors. Molecular and cell biology of liver fibrogenesis. Dordrecht, The Netherlands: Kluwer Academic Publishers, 85-98.
10. Coltrera MD and Gown AM (1991). PCNA/cyclin expression and BRDV uptakes define different subpopulations in different cell lines. J Histochem Cytochem 39:23-30.
11. Constantine VS and Mowry RW (1968). Selective staining of human dermal collagen: Part II. The use of Picrosirius Red F3BA with polarization microscopy. J Invest Dermatol 50: 419-423.
12. 4 integrin subunits are expressed by smooth muscle cells of human small vessels: A new localization in mesenchymal cells. J Histochem Cytochem 42:1221-1228.
13. Czaja MJ, Weiner FR, Flanders KC, Giambrone MA, Wind R, Biempica L, and Zern MA (1989). In vitro and in vivo association of transforming growth factor β with hepatic fibrosis. J Cell Biol 108:2477-2482.
14. Desmet VJ (1987). Cholestasis: Extrahepatic obstruction and secondary biliary cirrhosis. In: MacSween RNM, Anthony PP, and Scheuer PJ, editors. Pathology of the liver. Edinburgh: Churchill Livingstone, 364-423.
15. Desmoulière A, Geinoz A, Gabbiani F, and Gabbiani G (1993). Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103-111.
16. French SW, Miyamoto K, Wong K, Jui L, and Briere L (1988). Role of the Ito cell in liver parenchymal fibrosis in rats fed alcohol and a high fat-low protein diet. Am J Pathol 132:73-85.
17. Friedman SL (1990). Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis 10:20-29.
18. Friedman SL (1992). The molecular basis for Kupffer cell/ lipocyte interactions. In: Gressner AM and Ramadori G, editors. Molecular and cell biology of liver fibrogenesis. Dordrecht, The Netherlands: Kluwer Academic Publishers, 385-392.
19. Friedman SL (1993). The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328: 1828-1835.
20. Galand P and Degralt C (1989). Cyclin/PCNA immunostaining as an alternative to titriated thymidine pulse labeling for marking S phase cells in paraffin section from animals and human tissues. Cells Tissue Kin 22:383-392.
21. Geerts A, Vrijsen R, Ranterberg J, Burt AD, Schellinck P, and Wisse E (1989). In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. J Hepatol 9:59-68.
22. Geerts A, Lazou JM, De Bleser P, and Wisse E (1991). Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver. Hepatology 13:1193-1202.
23. Gown AM, de Wever N, and Battifora H (1993). Microwave-based antigenic unmasking. Appl Immunohistochemistry 1:256-266.
24. Gressner AM (1991). Liver fibrosis: Perspectives in pathobiochemical research and clinical outlook. Eur J Clin Chem Clin Biochem 29:293-311.
25. Gressner AM, Lofti S, Gressner G, Haltner E, and Kropf J (1993). Synergism between hepatocytes and Kupffer cells in the activation of fat storing cells (perisinusoidal lipocytes). J Hepatol 19:117-132.
26. Hamanque M, Kawaida K, Takao S, Shimazu H, Noji S, Matsumoto K, and Nakamura T (1992). Rapid and marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury. Hepatology 16:1485-1492.
27. Hines JE, Johnson SJ, and Burt AD (1993). In vivo responses of perisinusoidal cells (lipocytes) and macrophages to cholestatic liver injury. Am J Pathol 142:511-518.
28. Inuzuka S, Ueno T, Torimura T, Sata M, Abe H, and Tanikawa K (1990). Immunohistochemistry of the hepatic extracellular matrix in acute viral hepatitis. Hepatology 12:249-256.
29. Johnson SJ, Hillan KJ, Hines JE, Ferrier R, and Burt AD (1992a). Proliferation and phenotypic modulation of perisinusoidal (Ito) cells following acute liver injury: Temporal relationship with TGFβ1 expression. In: Clément B and Guillouzo A, editors. Cellular and molecular aspects of cirrhosis. INSERM/J Libbey Eurotext Ltd, Montrouge, France, 219-222.
30. Johnson SJ, Hines JE, and Burt AD (1992b). Macrophage and perisinusoidal cell kinetics in acute liver injury. J Pathol 166:351-358.
31. Kent G, Gay S, Inouye T, Bahu R, Minick OT, and Popper H (1976). Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci USA 73:3719-3722.
32. Kocher O, Skalli O, Bloom WS, and Gabbiani G (1984). Cytoskeleton of rat aortic smooth muscle cells: Normal conditions and experimental intimai thickening. Lab Invest 50:645-652.
33. Kountouras J, Billing BH, and Scheuer PJ (1984). Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat. Br J Exp Pathol 65:305-311.
34. Lennette DA (1978). An improved mounting medium for immunofluorescent microscopy. Am J Clin Pathol 69:647-648.
35. Mak K, Leo MA, and Lieber CS (1984). Alcoholic liver injury in baboons: Transformation of lipocytes to transitional cells. Gastroenterology 87:188-200.
36. Mak KM and Lieber CS (1988). Lipocytes and transitional cells in alcoholic liver disease: A morphometric study. Hepatology 8:1027-1033.
37. Matsuoka M, Pham NT, and Tsukamoto H (1989). Differential effects of interleukin-1a, tumor necrosis factor α, and transforming growth factor β1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 9:71-78.
38. Milani S, Herbst H, Schuppan D, Stein H, and Surrent C (1991). Transforming growth factors α1 and β2 are differently expressed in fibrotic liver disease. Am J Pathol 139:1221-1229.
39. Miyazaki H, Van Eyken P, Roskams T, De Vos R, and Desmet VJ (1993). Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: An immunohistochemical study. J Hepatol 19:353-366.
40. 3 thymidine radioautography. Histochemistry 101:13-20.
41. Nagy P, Schaff Z, and Lapis K (1991). Immunohistochemical detection of transforming growth factor β1 in fibrotic liver diseases. Hepatology 14:269-273.
42. Nakatsukasa H, Evarts RP, Hsia CC, and Thorgeirsson SS (1990). Transforming growth factor-β1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. Lab Invest 63:171-180.
43. Nouchi T, Tanaka Y, Tsukada T, Sato C, and Marumo F (1991). Appearance of α-smooth-muscle actin positive cells in hepatic fibrosis. Liver 11:100-105.
44. Ramadori G, Veit T, Schwögler S, Dienes HP, Knittel T, Rieder H, and Meyer KH (1990). Expression of the gene of α-smooth muscle-actin isoform in rat liver and in rat fat-storing (Ito) cells. Virchows Arch B Cell Pathol 59:349-357.
45. Ramadori G (1991). The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. New insights into pathophysiology of an intriguing cell. Virchows Arch B Cell Pathol 61:147-158.
46. Rockey DC, Boyles JK, Gabbiani G, and Friedman SL (1992). Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 24:193-203.
47. Ronnov-Jessen L and Petersen OW (1993). Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 68:696-707.
48. Saperstein LA, Jirtle RL, Farouk M, Thompson HJ, Chung KS, and Meyers WC (1994). Transforming growth factor-β1 and mannose 6-phosphatase/insulin-like growth factor-II receptor expression during intrahepatic bile-duct hyperplasia and biliary fibrosis in the rat. Hepatology 19:412-417.
49. Schmitt-Gräff A, Krüger S, Bochard F, Gabbiani G, and Denk H (1991). Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased humans livers. Am J Pathol 138:1233-1242.
50. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, and Gabbiani G (1986). A monoclonal antibody against α-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 103:2787-2796.
51. Skalli O, Schürch W, Seemayer T, Lagacé R, Montandon D, Pittet B, and Gabbiani G (1989). Myofibroblasts from diverse pathologic setting are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest 60: 275-285.
52. Slott PA, Liu MH, and Tavoloni N (1990). Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in rat. Gastroenterology 99:466-477.
53. Tanaka Y, Nouchi T, Yamane M, Irie T, Miyakawa H, Sato C, and Marumo F (1991). Phenotypic modulation in lipocytes in experimental liver fibrosis. J Pathol 164:273-278.
54. Tracy TFJ, Goerke ME, Bady PV, Sotello C, and Webert R (1993). Growth-related gene expression in early cholestatic liver injury. Surgery 114:532-537.
55. Wong L, Yamasaki G, Johnson RJ, and Friedman SL (1994). Induction of β-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 94:1563-1569.
56. Yokoi Y, Namihisa T, Kuroda H, Komatsu I, Miyazaki A, Watanabe S, and Usui K (1984). Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology 4:709-714.